Associated Targets of the Antioxidant Cardioprotection of Ganoderma lucidum in Diabetic Cardiomyopathy by Using Open Targets Platform: A Systematic Review
Table 3
mTOR score association with 49 heart diseases.
No.
Heart disease
Association score
Data types Genetic
Data types Known drug
Data types Literature
Data types Animal model
Overall
1
Heart disease
0.00041
0.79550
0.14161
0.19028
0.8588
2
Cardiomyopathy
0.00000
0.77847
0.11930
0.19028
0.8393
3
Hypertrophic cardiomyopathy
0.00000
0.77222
0.10214
0.00000
0.7978
4
Heart failure
0.00000
0.25000
0.05235
0.00000
0.2631
5
Dilated cardiomyopathy
0.00000
0.00000
0.07568
0.19028
0.2092
6
Congestive heart failure
0.00000
0.20000
0.02636
0.00000
0.2066
7
Diastolic heart failure
0.00000
0.20000
0.00000
0.00000
0.2000
8
Barth syndrome
0.00000
0.00000
0.00000
0.19028
0.1903
9
Coronary heart disease
0.00000
0.00000
0.12009
0.00000
0.1201
10
Diabetic cardiomyopathy
0.00000
0.10000
0.05391
0.00000
0.1135
11
Coronary artery disease
0.00000
0.00000
0.10961
0.00000
0.1096
12
Systemic scleroderma
0.00000
0.00000
0.09914
0.00000
0.0991
13
Cardiotoxicity
0.00000
0.00000
0.09016
0.00000
0.0902
14
Glycogen storage disease due to acid maltase deficiency